HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheng Hu Selected Research

Rosiglitazone (Avandia)

3/2016Joint effects of diabetic-related genomic loci on the therapeutic efficacy of oral anti-diabetic drugs in Chinese type 2 diabetes patients.
2/2012Association of a SLC30A8 genetic variant with monotherapy of repaglinide and rosiglitazone effect in newly diagnosed type 2 diabetes patients in China.
2/2008Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients.
9/2007[The effect of single nucleotide polymorphism SNP + 45 of the adiponectin gene on the rosiglitazone maleate response in patients with type 2 diabetes].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheng Hu Research Topics

Disease

66Type 2 Diabetes Mellitus (MODY)
10/2023 - 02/2007
40Neoplasms (Cancer)
04/2023 - 08/2010
32Insulin Resistance
02/2024 - 02/2007
23Obesity
03/2024 - 01/2007
18Non-alcoholic Fatty Liver Disease
12/2023 - 04/2013
14Inflammation (Inflammations)
02/2024 - 12/2016
13Wounds and Injuries (Trauma)
11/2023 - 12/2019
12Prostatic Neoplasms (Prostate Cancer)
02/2023 - 12/2011
12Pancreatitis
11/2022 - 07/2017
10Infections
11/2023 - 01/2018
9Fatty Liver
02/2024 - 01/2021
8Hyperglycemia
10/2023 - 08/2007
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2019
8Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2021 - 06/2009
7Neoplasm Metastasis (Metastasis)
01/2022 - 09/2018
6Thrombosis (Thrombus)
11/2023 - 01/2020
6Gestational Diabetes (Gestational Diabetes Mellitus)
01/2023 - 01/2017
5Body Weight (Weight, Body)
01/2024 - 11/2016
5Diabetes Complications
11/2023 - 11/2008
5Metabolic Diseases (Metabolic Disease)
01/2022 - 01/2015
5Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2015
5Glucose Intolerance
06/2021 - 01/2015
5Hypertension (High Blood Pressure)
06/2021 - 05/2011
5Weight Loss (Weight Reduction)
01/2019 - 10/2015
4Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 05/2015
4Neuralgia (Stump Neuralgia)
12/2022 - 04/2022
4Atherosclerosis
01/2022 - 05/2015
4Acute Liver Failure (Fulminant Hepatic Failure)
01/2021 - 05/2019
3Neuroinflammatory Diseases
04/2024 - 01/2022
3Stroke (Strokes)
04/2024 - 05/2015
3Brain Ischemia (Cerebral Ischemia)
04/2024 - 01/2020
3Myocardial Infarction
11/2023 - 05/2015
3Osteoporosis
02/2023 - 04/2018
3Malignant Pleural Effusion
01/2023 - 01/2022
3Hepatocellular Carcinoma (Hepatoma)
01/2023 - 01/2018
3Fibrosis (Cirrhosis)
01/2023 - 01/2021
3Pain (Aches)
04/2022 - 01/2021
3Lung Neoplasms (Lung Cancer)
01/2022 - 01/2020
3Albuminuria
01/2022 - 01/2015
3Abdominal Obesity
01/2022 - 01/2016
3Carcinoma (Carcinomatosis)
01/2021 - 08/2010
3Infertility (Sterility)
01/2021 - 10/2019
3Dyslipidemias (Dyslipidemia)
01/2020 - 08/2007

Drug/Important Bio-Agent (IBA)

41Glucose (Dextrose)FDA LinkGeneric
04/2024 - 02/2007
23Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2010
17LipidsIBA
01/2024 - 04/2013
16Insulin (Novolin)FDA Link
03/2024 - 08/2008
14HydrogelsIBA
04/2024 - 10/2020
13Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2015
9Uric Acid (Urate)IBA
01/2022 - 01/2015
8CytokinesIBA
03/2024 - 01/2017
8Blood Glucose (Blood Sugar)IBA
10/2023 - 11/2008
7Therapeutic UsesIBA
04/2024 - 08/2008
7Triglycerides (Triacylglycerol)IBA
01/2024 - 01/2016
6AcidsIBA
01/2023 - 01/2016
5Fatty Acids (Saturated Fatty Acids)IBA
12/2023 - 01/2016
5Peptides (Polypeptides)IBA
10/2023 - 08/2010
5MicroRNAs (MicroRNA)IBA
01/2023 - 12/2016
5Antiviral Agents (Antivirals)IBA
01/2023 - 01/2018
5CholesterolIBA
07/2022 - 06/2009
5Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021 - 05/2019
5repaglinide (Prandin)FDA Link
03/2016 - 08/2008
4Messenger RNA (mRNA)IBA
04/2024 - 04/2013
4LeptinIBA
03/2024 - 01/2014
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 08/2010
4CollagenIBA
08/2022 - 12/2021
4CreatinineIBA
01/2022 - 01/2015
4Bile Acids and Salts (Bile Acids)IBA
01/2022 - 01/2018
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 12/2017
4fibroblast growth factor 21IBA
10/2021 - 01/2014
4MicellesIBA
07/2021 - 01/2020
4HaptoglobinsIBA
11/2019 - 01/2018
4Gliclazide (Diamicron)IBA
01/2018 - 10/2014
4Rosiglitazone (Avandia)FDA Link
03/2016 - 09/2007
3GlucokinaseIBA
10/2023 - 08/2008
3Amino AcidsFDA Link
10/2023 - 01/2016
3Biocompatible Materials (Biomaterials)IBA
02/2023 - 01/2020
3AntioxidantsIBA
07/2022 - 01/2017
3Collagen Type III (Type III Collagen)IBA
01/2022 - 12/2021
3EnzymesIBA
01/2022 - 01/2019
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 07/2013
3Indicators and Reagents (Reagents)IBA
08/2021 - 01/2015
3ophiopogonin BIBA
01/2021 - 09/2018
3ChemokinesIBA
01/2021 - 12/2017
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2019
3AntigensIBA
01/2021 - 10/2003
3LDL CholesterolIBA
01/2019 - 01/2014
3C-PeptideIBA
11/2016 - 08/2007

Therapy/Procedure

26Therapeutics
02/2023 - 09/2007
11Drug Therapy (Chemotherapy)
11/2022 - 01/2018
7Injections
04/2024 - 01/2018
6Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2023 - 09/2018
6Electroacupuncture
12/2022 - 01/2020
6Gastric Bypass (Roux-en-Y Gastric Bypass)
08/2019 - 04/2016
5Radiotherapy
01/2023 - 01/2021
5Castration
10/2022 - 10/2016
4Immunotherapy
10/2022 - 08/2010
4Bariatric Surgery
01/2020 - 10/2015
3Glycemic Control
01/2021 - 05/2015
3Intravenous Injections
07/2018 - 12/2017